Statin use is associated with the reduction in hepatocellular carcinoma recurrence after liver surgery.
Elias KhajehArash Dooghaie MoghadamPegah EslamiSadeq Ali-Hasan-Al-SaeghAli RamouzSaeed ShafieiOmid GhamarnejadSepehr Abbasi DezfouliChristian RuppChristoph SpringfeldCarlos CarvalhoPascal ProbstSeyed Mostafa MousavizadehArianeb MehrabiPublished in: BMC cancer (2022)
Statins increase the disease-free survival of patients with HCC after liver surgery. These drugs seem to have chemoprevention effects that decrease the probability of HCC recurrence after liver transplantation or liver resection.